Skip to content
Verana-logo-horizontal-5
  • Clinicians
    • Member Value Tools
      • Practice Insights
      • Verana Trial Connect
      • Quality Measures Dashboards
        • MIPS Advisory Offerings
        • Manual Data Entry
    • Verana Research Network
    • Evolve Registry
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Partners
    • Societies
    • CROs
    • Technology and Data
  • Company
    • About
    • Team
    • Press
    • Blog
    • Careers
    • Privacy
      • Patient Privacy
      • Privacy Policy
  • Products
    • Ophthalmology Qdata
      • Anti-VEGF Market Tracker
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
      • Other Ophthalmic Conditions
    • Neurology Qdata
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
      • Other Neurological Conditions
    • Urology Qdata
      • Benign Prostatic Hyperplasia
      • Bladder Cancer
      • Prostate Cancer
      • Other Urological Conditions
    • Clinical Trials
      • Site Explorer
  • Solutions
    • Clinical Research
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
Contact Us
VeranaHealth_Logo
  • Clinicians
    • Member Value Tools
      • Practice Insights
      • Verana Trial Connect
      • Quality Measures Dashboards
        • MIPS Advisory Offerings
        • Manual Data Entry
    • Verana Research Network
    • Evolve Registry
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Partners
    • Societies
    • CROs
    • Technology and Data
  • Company
    • About
    • Team
    • Press
    • Blog
    • Careers
    • Privacy
      • Patient Privacy
      • Privacy Policy
  • Products
    • Ophthalmology Qdata
      • Anti-VEGF Market Tracker
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
      • Other Ophthalmic Conditions
    • Neurology Qdata
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
      • Other Neurological Conditions
    • Urology Qdata
      • Benign Prostatic Hyperplasia
      • Bladder Cancer
      • Prostate Cancer
      • Other Urological Conditions
    • Clinical Trials
      • Site Explorer
  • Solutions
    • Clinical Research
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
Contact Us
Press

New Study Shows Increasing Value of Real-World Data (RWD) in Clinical Trials

April 7, 2026
→
Press

New AAN Collaboration with Verana Health Aims to Improve Treatments and Discover Cures for Neurologic Disease

December 2018

→
Press

Verana Health Debuts New Cloud-Based Software Applications to Accelerate Life Science Innovation and Enhance Patient Care

October 2018

→
Press

Verana Health Appoints Three Key Executives as Company Builds Team to Expand Leading Specialty Data Platform

September 2018

→
Press

Verana Health Raises $30 Million Series C Led by GV to Accelerate Innovation in Healthcare

July 2018

→
Press

American Academy of Ophthalmology, DigiSight Technologies to Drive Innovations in Eye Health Through World’s Largest Specialty Clinical Database

November 2017

→
  • « Previous
  • 1
  • …
  • 33
  • 34
  • 35

For press inquiries please email [email protected]

Search
VeranaHealth_Logo

San Francisco | New York | Knoxville

Search

© 2026 Verana Health. All Rights Reserved.

Privacy Policy

Cookie Policy